Cipla has launched the generic version of Pirfenidone, used to treat Idiopathic Pulmonary Fibrosis, a progressive lung disease. The launch makes
In
The incidence of the illness in India is not known, but is expected to be higher than the prevalence in the US — about 30,000 new cases per year, The disease causes the lung to be replaced by scar tissue – though the cause of the illness is still not clear, varying from environmental illness to smoking, he said. But once it is diagnosed, about 50 per cent die in three years.
crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: